Article info
PDFInformed consent
Paper
Informed consent to HIV cure research
- Correspondence to Dr Danielle Bromwich, Department of Philosophy, University of Massachusetts Boston, 100 Morrissey BLVD, Boston, MA 02125, USA; danielle.bromwich{at}umb.edu
Citation
Informed consent to HIV cure research
Publication history
- Received October 2, 2015
- Revised April 21, 2016
- Accepted May 18, 2016
- First published June 10, 2016.
Online issue publication
September 28, 2022
Article Versions
- Previous version (28 September 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Can informed consent to research be adapted to risk?
- Understanding, interests and informed consent: a reply to Sreenivasan
- Decision aids for randomised controlled trials: a qualitative exploration of stakeholders’ views
- Cross-sectional assessment of patient attitudes towards participation in clinical trials: does making results publicly available matter?
- Involving patients in enrolment decisions for acute myocardial infarction trials
- Fair subject selection in clinical research: formal equality of opportunity
- Complex calculations: ethical issues in involving at-risk healthy individuals in dementia research
- How to keep high-risk studies ethical: classifying candidate solutions
- Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment
- Relative importance of informational items in participant information leaflets for trials: a Q-methodology approach